金艷濤,郭會軍,蔣自強




2.1人口學資料共納入98例病例資料,其中男69例(占70.4%),女29例(占29.6%);年齡19~63歲,平均(42±11)歲。感染原因:有償獻血56例(占57.1%),輸血4例(占4.1%),性傳播25例(占25.5%),不詳13例(占13.2%)。職業以農民為主56例(占57.1%),中學及以下文化程度78例(占79.6%)。


圖淋巴細胞計數與TLC的相關性



TLC(×106個/L)靈敏度特異度陽性預測值陰性預測值一致率<110034.7897.3380.0082.9582.65<120039.1396.0075.0083.7282.65<130043.4896.0076.9284.7183.67<140056.5292.0068.4287.3483.67<150060.8786.6758.3387.8480.61<160060.8782.6751.8587.3277.55<170069.5774.6745.7188.8973.47<180078.2670.6745.0091.3872.45



TLC(×106個/L)靈敏度特異度陽性預測值陰性預測值一致率<150032.2087.1879.1745.9554.08<160035.5984.6277.7846.4855.10<170044.0776.9274.2947.6257.14<180050.8574.3675.0050.0060.20<190062.7169.2375.5155.1065.31<200066.1066.6775.0056.5266.33<210074.5853.8570.9758.3366.33<220076.2746.1568.1856.2564.29



TLC(×106個/L)靈敏度特異度陽性預測值陰性預測值一致率<190054.0281.8295.9218.3757.14<200054.4781.8296.1519.5760.20<210067.8272.7395.1622.2268.37<220070.1154.5592.4218.7568.37<230077.0154.5593.0623.0874.49<240081.6136.3691.0320.0076.53<250087.3627.2790.4821.4380.61




1Wang H,Nishanian P,Fahey JL.Characterization of immune suppression by a synthetic HIV gp41 peptide[J].Cell Immunol,1995,161(2):236-243.

3中華醫學會感染病學分會艾滋病學組.艾滋病診療指南(2011版)[J].中華傳染病雜志,2011,29(10):629-640.
4金艷濤,蔣自強,郭會軍,等.無癥狀期HIV感染者生存質量評價[J].中國全科醫學,2012,15(12):4040.
5范思遠,弓孟春,楊瑩韻,等.早期抗逆轉錄病毒治療改善無癥狀HIV-1感染者預后[J].中華內科雜志,2011,50(6):526-528.
6World Health Organization.Antiretroviral therapy for HIV infection in adults and adolescents:recommendations for a public health approach (2010 version).2010:1-145.[2010-09-22].http://whqlibdoc.who.int/publications/2010/9789241599764-eng.pdf.
7張福杰,王健,王福生,等.國家免費艾滋病抗病毒藥物治療手冊[M].北京:人民衛生出版社,2012.
8Joint United Nations Programme on HIV/AIDS (UNAIDS).UNAIDS report on global AIDS epidemic[R].WHO Library Cataloguing-in-Publication Data,2010.
9Obirikorang C,Quaye L,Acheampong I.Total lymphocyte count as a surrogate marker for CD4count in resource-limited settings[J].BMC Infectious Diseases,2012,12:128.
10Stebbing J,Sawleshwarkar S,Michailidis C,et al.Assessment of the efficacy of total lymphocytecounts as predictors of AIDS defining infections in HIV-1 infected people[J].Postgrad Med J,2005,81(959):586-588.
11Daka D,Loha E.Relationship between total lymphocyte count (TLC) and CD4count among peoples living with HIV,Southern Ethiopia:a retrospective evaluation[J].AIDS Res Ther,2008(5):26.


14Wang Y,Liang S,Yu E,et al.Correlation analysis on total lymphocyte count and CD4count in HIV-infected patients:a retrospective evaluation[J].J Huazhong Univ Sci Technol Med Sci[J].2011,31(5):712-716.
15de Jong MA,Rudi Wisaksana,Hinta Meijerink,et al.Total lymphocyte count is a reliable surrogate marker for CD4cell counts after the first year of antiretroviral therapy:data from an indonesian cohort study[J].Tropical Medicine and International Health,2012,17(5):581-583.